PE20240359A1 - Metodos de purificacion de columna vectorial aav - Google Patents

Metodos de purificacion de columna vectorial aav

Info

Publication number
PE20240359A1
PE20240359A1 PE2023003271A PE2023003271A PE20240359A1 PE 20240359 A1 PE20240359 A1 PE 20240359A1 PE 2023003271 A PE2023003271 A PE 2023003271A PE 2023003271 A PE2023003271 A PE 2023003271A PE 20240359 A1 PE20240359 A1 PE 20240359A1
Authority
PE
Peru
Prior art keywords
complete
particles
raav
chromatographic medium
raav particles
Prior art date
Application number
PE2023003271A
Other languages
English (en)
Spanish (es)
Inventor
Vijesh Kumar
Mi Jin
Ohnmar Khanal
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of PE20240359A1 publication Critical patent/PE20240359A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
PE2023003271A 2021-06-11 2022-06-10 Metodos de purificacion de columna vectorial aav PE20240359A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US202263366094P 2022-06-09 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (1)

Publication Number Publication Date
PE20240359A1 true PE20240359A1 (es) 2024-02-27

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2023003271A PE20240359A1 (es) 2021-06-11 2022-06-10 Metodos de purificacion de columna vectorial aav

Country Status (13)

Country Link
US (1) US20240271159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351755A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525142A (cg-RX-API-DMAC7.html)
KR (1) KR20240021231A (cg-RX-API-DMAC7.html)
AU (1) AU2022289035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221540A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003646A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018191A2 (cg-RX-API-DMAC7.html)
IL (1) IL309070A (cg-RX-API-DMAC7.html)
MX (1) MX2023014809A (cg-RX-API-DMAC7.html)
PE (1) PE20240359A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022261663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
US20260085295A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. PARTITIONING ANION EXCHANGE CHROMATOGRAPHY FOR PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559429B2 (ja) * 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
AU2010227419A1 (en) * 2009-03-27 2011-10-20 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
EP3054006A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
EP3658250A4 (en) * 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus
JP2025535118A (ja) * 2022-10-11 2025-10-22 メイラグティーエックス ユーケー アイアイ リミティド Aavカプシドの精製のためのクロマトグラフィー方法

Also Published As

Publication number Publication date
US20240271159A1 (en) 2024-08-15
CA3221540A1 (en) 2022-12-15
JP2024525142A (ja) 2024-07-10
BR112023025999A2 (pt) 2024-02-27
AU2022289035A1 (en) 2024-01-04
IL309070A (en) 2024-02-01
KR20240021231A (ko) 2024-02-16
EP4351755A1 (en) 2024-04-17
EP4351755A4 (en) 2025-04-23
WO2022261663A1 (en) 2022-12-15
CO2023018191A2 (es) 2024-01-25
CL2023003646A1 (es) 2024-10-25
CL2026000535A1 (es) 2026-06-12
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
Ringden et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
BR112022021884A2 (pt) Proteínas que se ligam a nkg2d, cd16 e clec12a
AR069097A1 (es) Purificacion de anticuerpos por cromatografia de intercambio cationico
Oyama et al. Allogeneic stem cell transplantation for Evans syndrome
BR112021020204A2 (pt) Método para purificar anticorpo com região fc modificada
CL2019001324A1 (es) Anticuerpos anti-met, moleculas de unión a antígeno bispecificas que se unen a met y métodos de uso de los mismos.
JP2019529350A5 (cg-RX-API-DMAC7.html)
BR112021012667A2 (pt) Proteínas de ligação anti-pd-1 e métodos de uso destas
BR112017014805A2 (pt) anticorpos anti-cd3, anticorpos anti-cd123 e anticorpos biespecíficos que se ligam especificamente a cd3 e/ou cd123
BR112019012796A2 (pt) proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas
PH12014501773A1 (en) Interleukin-1 alpha abs and meethods of use
CO2023018191A2 (es) Métodos de purificación de columnas de vectores de aav
SG10201804483PA (en) Sterile chromatography resin and use thereof in manufacturing processes
MX2023006291A (es) Metodos para purificar proteinas que contienen fc.
KR102786553B1 (ko) 모사이동층 방식 크로마토그래피 분리 방법 및 모사이동층 방식 크로마토그래피 분리 시스템
EP1918372A4 (en) FOR BINDING TO IMMOBILIZABLE LOBULIN G-NUCLEIC ACID AND USE THEREOF
BR112022023908A2 (pt) Composições de vírus adenoassociados para restauração da função do gene pah e métodos de uso das mesmas
AR128806A1 (es) Métodos y composiciones para purificar partículas de virus adenoasociados
BR112022021447A2 (pt) Moléculas de ligação para o tratamento de câncer
UY39426A (es) Composiciones y métodos para tratar la esclerosis lateral amiotrófica (ela) con aav-mir-sod1
KR102754916B1 (ko) 모사이동층 방식 크로마토그래피 분리 방법 및 모사이동층 방식 크로마토그래피 분리 시스템
JP2017526735A (ja) 抗体を精製するための方法
US11839835B2 (en) Simulated moving-bed type chromatographic separation method and simulated moving-bed type chromatographic separation system
JP2006064631A (ja) 擬似移動層方式クロマト分離方法および装置
EP4498078A1 (en) Simulated moving-bed chromatographic separation method and simulated moving-bed chromatographic separation system